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INTRODUCTION
Adenovirus 2 (Ad2) belongs to subgroup C of adenoviruses,
which have the ability to transform cells. The virion is 80
nm in diameter and is composed of a core that includes the
viral DNA genome of about 36 kb and four proteins, and a
shell that comprises at least 15 different structural proteins
organized in a complex capsid (Pettersson, 1984; Akusjärvi
et al., 1986; Stewart et al., 1991). Whereas the majority of
the viral genome is transcribed by RNA polymerase II (see
Ziff, 1980; Tooze, 1982; Flint, 1986; Akusjärvi et al., 1986),
the two virus-associated (VA) RNAs, VA RNAI and VA
R N AII (Reich et al., 1966) are synthesized by RNA poly-
merase III (Price and Penman, 1972; Mathews, 1975;
Akusjärvi et al., 1980; Akusjärvi et al., 1986). These two
small, noncoding RNAs are about 160 nucleotides long
(Akusjärvi et al., 1980) and are transcribed from the r-strand
at about 30 map units in the genome (Mathews, 1975;
Akusjärvi et al., 1980; Akusjärvi et al., 1986). Although the
genes for these RNAs are arranged in tandem and separated
by a short DNA spacer (Mathews, 1975; Mathews and Pet-
tersson, 1978; Akusjärvi et al., 1980) they are differentially
expressed. Both RNAs are produced early in infection but
VA RNA I synthesis increases rapidly in the late phase and
becomes the most abundant RNA in the cytoplasm of
infected cells (Söderlund et al., 1976). 
Although regulation of Ad2 mRNA formation late in
infection takes place extensively in the cell nucleus, includ-
ing control of transcription and post-transcriptional events
such as methylation, splicing, polyadenylation and trans-
port (se  McGrogan and Raskas, 1977; Nevins and Darnell,
1978; Philipson 1979; Ziff, 1980; Tooze, 1982; Darnell,
1982; Sharp, 1984; Flint, 1986), once in the cytoplasm, a
complex series of events regulate the expression of the Ad2
genome at the level of protein synthesis. 
During the late phase of infection, cellular protein syn-
thesis is inhibited while viral protein production is enhanced
(Beltz and Flint, 1979). The mechanism whereby the cel-
lular translational apparatus is selectively engaged in viral
protein synthesis is not fully understood despite consider-
able effort expended to try to understand the different
aspects of this phenomenon (Mathews, 1990; Zhang and
Schneider, 1993). Translational control in adenovirus
infected cells involves the participation of the cellular
kinase DAI (double-stranded RNA-activated inhibitor of
translation) and the small viral VA RNAI (see Mathews,
1990; Mathews et al., 1990; Mathews and Shenk, 1991).
DAI, also known as the interferon-induced protein kinase
(p68) is present in a latent form in most cells (Kostura and
Mathews, 1989; Mathews and Shenk, 1991). It is activated
by low concentrations of double-stranded (ds) RNA, proba-
bly generated during viral infection by symmetrical tran-
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We have examined the cellular distribution of the
double-stranded RNA-activated protein kinase DAI in
adenovirus 2 (Ad2) -infected and uninfected HeLa cells.
In uninfected cells DAI was found to be concentrated in
the cytoplasm. In addition, DAI was localized in the
nucleoli and diffusely distributed throughout the nucle-
oplasm. Cells treated with -interferon displayed a sim-
ilar pattern of distribution for DAI. When RNA poly-
merase I activity was inhibited by the drug actinomycin
D, nucleoli segregated and DAI was found to colocalize
with the dense fibrillar region of the nucleoli. During
mitosis, the distribution of DAI paralleled that of rRNA.
In adenovirus-infected cells the localization of DAI was
similar to that in uninfected interphase cells. VA RNAI
was detected in Ad2-infected cells by 10-14 hours post-
infection as fine dots in the nucleoplasm. By 18-24 hours
post-infection, VA RNAI appeared in bigger and more
abundant dots in the nucleoplasm and the cytoplasm
was intensively labeled. Transient expression of the VA
RNAI gene in uninfected cells resulted in a similar local-
ization of the RNA. Our results are consistent with a
role for DAI and VA RNAI in protein synthesis and
suggest that DAI may play an early role in ribosome
biogenesis in the nucleolus in addition to its cytoplasmic
role in translation. 
Key words: adenovirus, nucleolus, translation, RNA localization
SUMMARY
Organization of the double-stranded RNA-activated protein kinase DAI and
virus-associated VA RNAI in adenovirus-2-infected HeLa cells
Luis F. Jiménez-García*, Simon R. Green, Michael B. Mathews and David L. Spector†
Cold Spring Harbor Laboratory, Cold Spring Harbor, New York 11724, USA
*Present address: National Autonomous University of Mexico, Departamento de Biology, Mexico, DN Mexico
†Author for correspondence
12
scription of the genome (Maran and Mathews, 1988), but
high concentrations of dsRNA prevent such an activation
(Mathews et al., 1990; Mathews and Shenk, 1991). Upon
binding of dsRNA, the protein displays two kinase activities.
First, the enzyme autophosphorylates, resulting in unmask-
ing of its second activity, which is to phosphorylate the a-
subunit of the eukaryotic translation initiation factor-2 (eIF-
2). In uninfected cells, DAI remains in a latent, inactive form
and does not phosphorylate eIF-2, allowing this factor to
engage in multiple rounds of initiation of protein synthesis
(Schneider et al., 1984, 1985; Reichel et al., 1985; Mathews,
1990; Mathews et al., 1990; Mathews and Shenk, 1991).
A mutant virus lacking the gene for VA RNAI g r o w s
poorly, and the defect was ascribed to a lesion in protein
synthesis (Thimmappaya et al., 1982; Mathews, 1990; Math-
ews and Shenk, 1991). The sequence of VA RNAI is known
(Akusjärvi et al., 1980; Pe’ery et al., 1993). It forms exten-
sive secondary structure (Furtado et al., 1989; Mellits and
Mathews, 1988; Pe’ery et al., 1993) and functions to pre-
vent DAI activation. In fact, VA RNAI can bind to DAI
(Katze et al., 1987; Galabru et al., 1989; Mellits et al.,
1990a) mediated principally by its duplexed apical stem
(Mellits et al., 1990a; Ghadge et al., 1991; Clarke et al.,
unpublished), while another structural feature, the central
domain, is responsible for the blocking function (Mellits and
Mathews, 1988; Furtado et al., 1989; Mellits et al., 1990b).
During adenovirus infection, VA RNAI prevents the acti-
vation of DAI by viral dsRNA (Maran and Mathews, 1988),
thereby maintaining the rate of protein synthesis in the cell
(Mathews, 1990; Mathews et al., 1990; Mathews and
Shenk, 1991). In addition, it has been proposed that the VA
RNAI-DAI system contributes to the preferential transla-
tion of viral mRNAs late in infection (O’Malley et al., 1989;
Svensson and Akusjärvi, 1985). 
In the present study we have used polyclonal and mono-
clonal antibodies to DAI and a DNA probe to Ad2 VA RNAI
to localize these molecules in the cell by immunoflu o r e s-
cence microscopy and in situ hybridization. Single- and
double-label (data not shown) experiments have shown that
DAI and VA RNAI localize diffusely in the cytoplasm of
infected cells late in infection. Furthermore, DAI was found
in the nucleolus and nucleoplasm of uninfected and infected
cells. VA RNAI was localized as discrete and abundant small
round bodies in the nuclei of infected cells or uninfected
cells transfected with the VA RNAI gene. Our results pro-
vide cytochemical evidence to support the role of DAI and
VA RNAI in protein synthesis late in adenovirus infected
cells, and also suggest a possible role for DAI in the early
steps of ribosome biogenesis within the nucleolus. 
MATERIALS AND METHODS
Cells, virus and infection
HeLa cells were grown on glass coverslips for 1-2 days in Dul-
becco’s modified Eagle’s medium (Gibco) containing 10% fetal
bovine serum. Cells were infected with wild type adenovirus-2
(Ad2) at a multiplicity of infection (moi) of 30 plaque forming
units (pfu)/cell. After 1 hour of adsorption, the monolayers were
rinsed with PBS and fresh medium was added. Further incubation
for 7, 10, 14, 18 or 24 hours was carried out before in situ hybrid-
ization or immunocytochemistry.
Antibodies and probes
Polyclonal antibodies were prepared as described (Green and
Mathews, 1992). Monoclonal antibody to DAI (Laurent et al.,
1985) was a gift from A. G. Hovanessian (Institut Pasteur). Human
autoantibody to fibrillarin was provided by R. L. Ochs (Scripps
Research Institute). Approximately 3 µg of DNA encoding VA
RNAI (plasmid pT7VA/Ad2I; Mellits et al., 1990b) was labeled
by nick translation in the presence of 50 µM of bio-11-dUTP
(Sigma), dATP, dCTP and dGTP. The size of the resulting frag-
ments was monitored by electrophoresis in a 1% agarose gel. Nick
translation reactions were stopped when a fragment size of about
200 base pairs was obtained. The probe was purified through a
Sephadex G-50 (Boehringer Mannheim) column and stored at
- 20°C until use.
Immunofluorescence
After fixation for 15 minutes with 2% paraformaldehyde or for 3
minutes at - 20°C with 100% methanol, immunofluorescence was
performed as described (Spector and Smith, 1986) using poly-
clonal antibodies to DAI at a dilution of 1:30 or monoclonal anti-
bodies to DAI at a dilution of 1:5 in Tris buffered saline (TBS:
20 mM Tris-HCl, pH 7.6, 150 mM NaCl), with 20 mM NaN3 and
1% Tween-20. As controls, we performed immunofluorescence
with preimmune serum for the polyclonal antibody or with anti-
bodies to DAI preabsorbed with immunoaffinity purified (Galabru
and Hovanessian, 1987) or glycerol gradient fractionated (Kostura
and Mathews, 1989) DAI. Incubation times with the first antibody
were either 1 hour at room temperature or 16 hours at 4°C. Texas
Red-conjugated horse anti-mouse, Texas Red-conjugated goat
anti-rabbit (Vector, Burlingame California) or FITC-conjugated
goat anti-mouse (Organon-Teknika, West Chester, PA) secondary
antibodies were used at a dilution of 1:20 in TBS plus 5% bovine
serum albumin (BSA) and 5% normal goat serum (NGS). Cover-
slips were mounted in anti-fade medium (90% glycerol, 10% PBS
plus 1 mg/ml of paraphenylenediamine). The final pH was
adjusted to 8.0 with 0.5 M carbonate-bicarbonate buffer, pH 9.0.
Cells were examined with a Nikon (Nikon Inc., Melville, New
York) FXA epifluorescence microscope equipped with a · 60, 1.4
NA objective lens.
In situ hybridization and detection
Cells were fixed with freshly made 2% or 4% paraformaldehyde
in PBS, pH 7.3, for 15 minutes at room temperature at 0, 7, 10,
14, 18 and 24 hours post-infection (hpi). After rinsing in PBS (3·
10 minutes each), cells were permeabilized with 0.2% Triton X-
100/0.5% NGS for 5 minutes at 4°C, then rinsed in PBS (3· 10
minutes each) and in 2· SSC (5 minutes). For each coverslip, 750
ng of nick translated DNA encoding VA RNAI and 20 µg of
carrier E. coli tRNA were dried down in a Speed Vac (Savant).
The probe and tRNA were denatured by heating in 10 ml of deion-
ized formamide for 10 minutes at 70°C. The probe was chilled
on ice immediately and hybridization buffer containing 4 µl of
5% BSA, 4 µl of 50% dextran sulfate, and 2 µl of 20· SSC was
added to each tube so that the final concentration in the hybrid-
ization mixture was about 40 ng/µl of the VA RNAI probe, 1
µg/µl of E. coli tRNA, 4· SSC, 1% BSA and 10% dextran sul-
fate. Then, 20 µl of hybridization mixture was placed onto each
coverslip. Coverslips were inverted onto a slide, sealed with
rubber cement, and incubated in a humidified chamber for 16
hours at 42°C. After rinsing in 2· SSC, 50% formamide at 37°C,
2· SSC and 1· SSC at room temperature for 30 minutes each,
cells were incubated in 4· SSC, 0.25% BSA, and 2 µg/µl avidin-
FITC (V ctor, Burlingame, California) for 90 minutes at room
temperature in a humidified chamber in the dark. Coverslips were
then rinsed in 4· SSC for 30 minutes at room temperature, 4·
SSC, 0.1% Triton X-100 for 10 minutes and 4· SSC three times
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for 10 minutes each. Coverslips were mounted in 90% glycerol,
10% PBS, containing 1 mg/ml paraphenylenediamine as an anti-
oxidant to prevent bleaching. Cells were examined with a Nikon
FXA epifluorescence microscope.
In situ hybridization-immunofluorescence
combined protocols
Immunofluorescence following in situ hybridization was con-
ducted as described (Huang and Spector, 1991) with the follow-
ing modifications. Briefly, cells were hybridized as above and after
incuba ion in FITC-avidin to detect the hybrids, and washes with
4´ SSC, cells were placed in PBS for 10 minutes and incubated
with monoclonal antibody to DAI as described above. The inverse
procedure, antibody labeling followed by in situ hybridization,
was also carried out and produced similar results.
Confocal laser scanning microscopy
A Zeiss (Carl Zeiss Inc., Thornwood, New York) confocal laser
Fig. 1.Localization of DAI in uninfected HeLa cells. Immunofluorescence using polyclonal (a) or monoclonal (c) antibodies, and
corresponding differential interference contrast images (b, d) of HeLa cells shows the presence of DAI in the cytoplasm, and nucleoli.
The nucleoplasm is also slightly labeled. Coiled bodies were also labeled with polyclonal antibodies to DAI (a, arrows). Cells incubated
with preimmune serum (e) or monoclonal antibodies to DAI preabsorbed with immunoaffinity purified (Galabru and Hovanessian, 1987)
(f) or glycerol gradient fractionated DAI (Kostura and Mathews, 1989) (g) used as primary antibodies, showed no signal. 
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scanning microscope, equipped with a ´ 63/1.4 NA oil immersion
lens and an argon ion laser (wavelength, 488 nm) to excite FITC-
fl uorescence was used for optical sectioning. Data sets of optical
sections were collected at 250 nm intervals through each nucleus.
Single optical sections and left/right stereo pairs of labeled nuclei
reconstructed from serial optical sections were generated using the
Zeiss Confocal Laser Scanning software version 2.03. Images
were recorded on a Sony color video printer (Mavigraph) and on
Kodak T-Max 100 film or Kodak Ektachrome 100 HC film using
a Matrix Multicolor image recording system.
Nuclease digestions
Paraformaldehyde fixed cells were treated with either DNase I or
RNase A at a concentration of 100 µg/ml for 2 hours at room
temperature. After extensive washes cells were prepared for in situ
hybridization as described above.
Post-embedding immunoelectron microscopy
Monolayers of HeLa cells were fixed in 4% paraformaldehyde
plus 0.05% glutaraldehyde in PBS, pH 7.3, dehydrated in ethanol
and embedded in Lowicryl K4M resin. Thin sections (80 nm) were
cut with a Reichert-Jung Ultracut E ultramicrotome using a
Diatome diamond knife and were mounted on gold grids. The
grids were floated in TBS for 60 minutes at room temperature and
incubated with monoclonal antibody to DAI at a dilution of 1:2
in TBS for 16 h at 4°C. Then 15 nm colloidal gold-conjugated
goat anti-mouse IgG (Amersham) (diluted 1:20 in TBS) was used
as secondary antibody for 60 minutes at room temperature. After
rinsing with TBS for 10 minutes, grids were washed with distilled
water and stained with uranyl acetate and lead citrate. The sam-
ples were observed with a Hitachi H-7000 transmission electron
microscope (Hitachi Ltd., Rockville, MD) operating at 75 kV.
Drug studies
HeLa cells growing on coverslips were exposed to 0.2 µg/ml of
actinomycin D for 4 hours at 37°C (Ochs et al., 1985a). After
drug treatment, cells were immunolabeled as described above with
a monoclonal antibody to DAI or human autoantibody against fib-
rillarin at a dilution of 1:200. Detection was carried out with sec-
ondary antibodies coupled to FITC or Texas Red, respectively.
Transfection
HeLa cells growing on coverslips were transfected with 2.5
µg/coverslip of plasmid pMHVA (Mellits and Mathews, 1988) for
6 hours, using a modified calcium phosphate technique (Wigler et
al., 1978). Cells were then fixed and processed for in situ hybrid-
ization using the pT7VA/Ad2I probe 24, 48 and 60 hours post-
transfection. Control cells were transfected with 2.5 µg of plas-
mid pUC119. 
Interferon treatment
HeLa cells growing on coverslips were treated with a -interferon
(obtained from Paul Trotta, Schering Corp., Bloomfield, New
Jersey) at a concentration of 800 units/ml for 18 hours at 37°C.
After the treatment, cells were immunolabeled with monoclonal
antibody to DAI.
RESULTS 
DAI localizes in the cytoplasm and nucleoli of
uninfected and Ad2 infected HeLa cells
We have localized DAI in the cytoplasm and nucleoli of
uninfected HeLa cells with either polyclonal (Fig. 1a) or
monoclonal (Fig. 1c) antibodies directed against the pro-
tein. Intense and almost homogeneous signal was observed
in the cytoplasm. In addition, a weaker fluorescence was
detected in the nucleoli and also a diffuse labeling of the
nucleoplasm was observed. The labeling with polyclonal
and monoclonal antibodies was similar but with the poly-
clonal antibody we consistently observed the staining of
additional nuclear bodies that we identified as coiled bodies
(Fig. 1a). The significance of the presence of DAI in the
coiled bodies is unclear. Coiled bodies are ribonucleopro-
tein structures that contain factors related to pre-rRNA and
pre-mRNA metabolism (Brasch and Ochs, 1992). However,
they are not present in all cells and they appear to be char-
cteristic of transformed cells (Spector et al., 1992).
The specificity of the antibodies used in this study was
demonstrated by performing immunofluorescence with a
preimmune serum (Fig. 1e) and with anti-DAI antibody,
which was preabsorbed with purified DAI protein (Fig. 1f-
g). In both cases, no signal was observed in the cytoplasm,
nucleoplasm or nucleolus. The specificity of the monoclonal
antibody was previously demonstrated by immunoblot and
immunoprecipitation (Laurent et al., 1985). This antibody
L. F. Jiménez-García and others
Fig. 2.Immunofluorescent localization of DAI in uninfected a -
interferon treated HeLa cells. Cells untreated (a) or treated with a -
interferon (b) both display cytoplasmic and nucleolar localization
of DAI.
15Localization of DAI and VA RNAI
was used for all subsequent immunolocalization experi-
ments. Since DAI is an interferon-induced protein we deter-
mined the localization of this kinase aftera -interferon treat-
ment. Interferons (IFNs) are cytokines with antiviral, cell
growth regulatory and immunomodulatory activities
(Pestka et al., 1987). Binding of IFNs to the cell surface
induces the synthesis of several proteins, including DAI,
that are localized to the cytoplasm and nuclei. Treatment
of HeLa cells with 800 units/ml of a -interferon did not alter
the distribution of DAI, although the signal appeared
brighter (Fig. 2b) than in non-treated cells (Fig. 2a). Other
proteins such as the Mx family (Pavlovic and Staehli,
1991), and some isoenzymes from the (2¢ -5¢ )oligoadenylate
synthetase family have been localized to the nucleus
(Chebath et al., 1987). Recently, the murine IFN-induced
72 kDa protein encoded by the Ifi204 gene was also found
in the nucleolus (Choubey and Lengyel, 1992). These
observations and our results suggest that nuclear localiza-
tion may be a common characteristic of IFN-induced pro-
teins.
To correlate the distribution of DAI with other cytoplas-
mic and nucleolar components we monitored the behavior
of DAI during mitosis (Fig. 3). Label remained distributed
in the cytoplasm during the different phases of mitosis
Fig. 3.Immunofluorescent localization of DAI in uninfected HeLa
cells during mitosis. Interphase cells (a) showed cytoplasmic
staining as well as faint labeling in nucleoli and nucleoplasm.
During prophase (b), nucleolar DAI is diffusely distributed as the
nucleolus breaks down. In metaphase (c), anaphase (d) and
telophase (e) the chromosomes are not labeled. By early G1 (f)
DAI appears in the newly forming nucleoli (arrows). 
Fig. 4.Distribution of DAI in uninfected actinomycin D-treated
HeLa cells. Double-label immunofluorescence of cells with anti-
DAI (a) and anti-fibrillarin (b) antibodies after treatment with 0.2
µg/ml of actinomycin D for 4 hours shows cytoplasmic staining
for DAI (a). Colocalization of DAI and fibrillarin is observed in
the segregated nucleoli (a-c, arrows). (c) Corresponding
differential interference contrast image.
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Fig. 5.Ultrastructural localization of DAI in uninfected HeLa cells using immunoelectron microscopy. DAI is present in ribosome
enriched areas of the cytoplasm (a,b), where cytoskeletal elements are observed (arrows) but are not immunolabeled. DAI is observed to a
lesser extent in the nucleoplasm and the fibrillar portion of the nucleolus (a,c). Higher magnification of the cytoplasm (small square area
in (a)) is shown in (b). Higher magnification of the nucleolus (large rectangular area in (a)) is shown in (c). m, mitochondrion; v, vacuole;
FC, fibrillar center; DFC, dense fibrillar component; G, granular component.
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(Fig. 3a-f), but was excluded from the chromosomes. By
late telophase and early G1 phase, DAI appeared in the
newly forming nucleoli in every daughter cell (Fig. 3f,
arrows). The distribution of DAI during interphase and mito-
sis parallels the distribution of rRNA as visualized by in situ
hybridization (Jiménez-García et al., unpublished). Because
of the nucleolar localization and its behavior during mito-
sis, we studied the distribution of DAI in actinomycin D
(ActD)-treated cells (Fig. 4). ActD inhibits transcription by
RNA polymerase I producing well defined morphological
changes in the nucleolus (Ochs et al., 1985a). Upon ActD
treatment, the three different components of the nucleolus
spatially segregate in such a way that they are easily dis-
tinguishable from each other when observed using different
staining techniques. This pattern is characterized by the pres-
ence of a large nucleolar body that is composed of the gran-
ular portion, and small buds that are constituted by the fib-
rillar portion, i.e. the dense fibrillar component and the
fibrillar centers. When HeLa cells were treated in this
manner, and then double labeled with anti-DAI and anti-fib-
rillarin antibodies, DAI and fibrillarin (which is a marker
for the dense fibrillar component of the nucleolus; Ochs et
al., 1985a), were segregated and colocalized to the fib r il l ar
portion of the nucleolus (Fig. 4a,b).
The distribution of DAI in the cell was determined at
high resolution by conducting immunoelectron microscopy
on HeLa cell sections with monoclonal antibodies to DAI
(Fig. 5). Label was observed in the ribosome-enriched areas
of the cytoplasm, where cytoskeletal elements (arrows)
were also visible but were not immunolabeled (Fig. 5a,b).
Vacuoles and other organelles such as mitochondria, were
unlabeled. The nucleoplasm was diffusely labeled (Fig. 5a).
In the nucleolus, label was observed mainly in the dense
fi brillar component although little label was visualized in
the granular compartment and the fibrillar centers (Fig.
5a,c). To examine the distribution of DAI in Ad2-infected
cells, infected HeLa cells were immunolabeled with mon-
oclonal antibodies to DAI after hybridization to a total Ad2
probe to identify the infected cells and to determine the
stage of infection that they had reached. At early and late
stages after infection (visualized as cells with label as fine
dots or abundant inclusions in the nucleus, respectively),
DAI was observed both in the cytoplasm and in the nucle-
olus (Fig. 6a, arrows). Some diffuse label was also present
in the nucleoplasm. Cytoplasmic viral RNA and DAI (Fig.
6b) were both diffusely distributed late in infection (heav-
ily stained cell in Fig. 6b).
VA RNAI is present in the cytoplasm and nucleus
of Ad2-infected HeLa cells late in infection
VA RNA I is produced abundantly during the late phase of
adenovirus infection (Soderlund et al., 1976). We per-
formed in situ hybridization in HeLa cells infected with
Ad2 for 24 hours to determine the cellular distribution of
this RNA (Fig. 7). Hybridization signal was intense and
diffusely distributed in the cytoplasm of infected cells (Fig.
7a). In the nucleus, VA RNAI was found in the form of
small very intense bright round bodies, which were abun-
dant and distributed throughout the nucleoplasm (Fig. 7a,
arrowheads). In addition, VA RNAI was also detected in
more elaborate ring-shaped viral inclusions. The nucleo-
lus, on the other hand, was unlabeled. To confirm that the
signal observed in the nucleus and cytoplasm was specific
for RNA and not for single-stranded viral DNA that is pro-
duced during Ad2 DNA replication (Lechner and Kelly,
1977), we performed nuclease digestions prior to the
hybridization protocol. Cells incubated in 100 µg/ml of
DNase I for 2 hours at room temperature still exhibited
hybridization signal in the cytoplasm and the small
rou ed bodies in the nuclei (Fig. 7c). However, RNase A
treatment prior to hybridization eliminated the hybridiz-
ation signal in the cytoplasm and in the round nuclear
inclusions (Fig. 7d). These data show that VA RNAI i s
contained within the small round inclusions. Control in situ
hybridizations conducted without probe gave no signal
(data not shown). To determine the pattern of expression
Fig. 6. Localization of DAI in Ad2-infected HeLa cells. In situ
hybridization with a total genomic Ad2 DNA probe to identify
infected cells (b), followed with anti-DAI (a) in the same cells
shows the cytoplasmic distribution of DAI. In addition, the
nucleolus and nucleoplasm are labeled for DAI. Cells in an early
stage of infection are indicated by an arrow (a,b). Double arrows
show a cell late in infection.
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of VA RNAI during the course of infection we performed
in situ hybridization at 7, 10, 14, 18 and 24 hpi. For com-
parison, we also used an Ad2 genomic probe to localize
total Ad2 RNA (Fig. 8). Total viral RNA was widely dis-
tributed and gave a very intense signal at 10-14 hpi (Fig.
8a) and 18-24 hpi (Fig. 8b). VA RNAI was first detected
by 10-14 hpi as fine dots in the nucleoplasm and diffusely
distributed in the cytoplasm of infected cells (Fig. 8c). By
18-24 hpi these fine and rounded bodies increased in size
and number while the label in the cytoplasm also became
more intense (Fig. 8d). No signal was observed before 10
hpi either in the nucleus or in the cytoplasm (data not
shown). 
To determine the three-dimensional distribution of the
viral inclusions enriched in VA RNA in the infected nuclei,
we reconstructed images of infected cells after in situ
hybridization using a confocal laser scanning microscope.
Fig. 9 shows a stereopair (where different planes of focus
are displayed in the same picture) revealing the abundance
of these bodies and their distribution at the different depths
of the nuclei. The cytoplasm is observed to be homoge-
neously labeled. 
We next wanted to determine whether the pattern of
expression for VA RNAI reflects the intrinsic distribution
characteristics of this molecule, or whether it is influenced
by events occurring during viral infection. To this end,
uninfected HeLa cells were transfected with the DNA
encoding VA RNAI and were hybridized in situ after 24,
48 and 60 hours (Fig. 10). Cells transfected with the plas-
mid pUC119 containing no VA insert were not labeled (Fig.
10a). By 24 hours after transfection with a plasmid con-
taining the VA RNA gene, VA RNAI started to appear as
fi ne dots in the nucleoplasm (Fig. 10b). By 48 hours after
transfection, VA RNAI was present as bigger dots in the
nucleus and as a faint cytoplasmic distribution (Fig. 10c).
By 60 hours post-transfection, the cytoplasm was even more
heavily labeled than at 48 hours, and the nuclei were filled
with bigger and more abundant round bodies, that were not
present in the nucleolus (Fig. 10d). Therefore, the pattern
of expression of VA RNAI in transfected and Ad2 infected
cells was similar. 
DISCUSSION
We document here the localization of DAI in the cytoplasm
and nucleolus of both uninfected and Ad2-infected HeLa
cells; this pattern of distribution remained unchanged after
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Fig. 7. Localization of VA RNAI in HeLa cells infected with Ad2 for 24 hours, using in situ hybridization. (a) VA RNAI appears to be
localized in abundant small round dots in the nucleus (arrowheads) as well as being diffusely distributed in the cytoplasm.
(b) Corresponding differential interference contrast image. The hybridization signal (dots) are still observed after DNase I pre-treatment
(c) but are not observed after RNase A pre-treatment (d).
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treatment of uninfected cells with a -IFN, although IFN
treatment elevates the amount of DAI protein in the cell by
a factor of 5 to 10 (Hovanessian, 1989). Considering the
role DAI has in the initiation of translation it was antici-
pated that this protein would be present in the cytoplasm.
It has been shown previously that many of the factors impli-
cated in protein synthesis are compartmentalized in the
cytoplasm. Active polysomes are associated with the
cytoskeleton (Lenk et al., 1977) and translational initiation
factors are associated with ribosomes and the cytoskeleton
(Howe and Hershey, 1984). Our results confirm that at least
one site of action for DAI is in the cytoplasm. The pres-
ence of DAI in the nucleolus and to a lesser extent in the
nucleoplasm was unexpected. Interestingly, it was reported
recently that eIF-4E is also partially located in the nucleus
(Lejbkowicz et al., 1992) suggesting that many of the pro-
teins participating in translation may also have roles in
nuclear function. One may speculate as to the possible role
of DAI in the nucleus. Since the nucleolus is known to be
the site of pre-rRNA synthesis and ribosome assembly
(Scheer and Benavente, 1990), the nucleolar localization of
DAI may indicate that it has a role in the early stages of
ribosome biogenesis. The nucleoplasmic staining may rep-
resent DAI migrating from the nucleolus to the cytoplasm.
Alternatively, the nucleoplasmic presence of DAI in unin-
fected cells may be correlated with its ability to phospho-
rylate histones (Hovanessian, 1989) or other nuclear pro-
teins (Ghosh and Baltimore, 1990). 
Many nucleolar proteins are known to be present around
the mitotic chromosomes and organized as prenucleolar
bodies (PNB) that fuse to the nucleolar organizer (NOR),
contributing to the newly formed interphase nucleolus at
telophase (De la Torre and Giménez-Martín, 1982; Ochs et
al., 1985b; Jiménez-García et al., 1989). During mitosis
DAI was not found in PNB at telophase. DAI was first
detected after mitosis during early G1. At this stage, the
nucleoli are already active in transcription (De la Torre and
Giménez-Martín, 1982), suggesting an association with the
early phases of ribosome biogenesis. Since DAI has a strong
cytoplasmic localization in addition to its nucleolar distri-
bution, we considered the possibility that DAI may be asso-
ciated with ribosomal subunits. Therefore, we treated cells
with actinomycin D which inhibits ribosomal RNA syn-
thesis and results in a segregation of nucleolar components.
The behavior of nucleolar DAI upon actinomycin D treat-
ment was the same as that of the nucleolar protein fibril-
larin. It is known that fibrillarin is present in PNBs and it
is the major nucleolar protein found in the dense fibrillar
component of the nucleolus (Ochs et al., 1985a). Interest-
Fig. 8. Localization of VA RNAI at different time points after Ad2
infection by in situ hybridization. The first detectable VA RNAI
signal appeared at about 10 hpi (c) as very fine dots in th
nucleoplasm, in association with the growing viral inclusions that
contain ssDNA and RNA (a). Some diffuse cytoplasmic signal
was also observed. By 24 hpi VA RNAI was present as larger dots
in the nucleus and diffusely in the cytoplasm (d). Total Ad2 RNA
at 10 hpi (a) or 24 hpi (b) is shown for comparison.
Fig. 9. Stereo images of VA RNAI
localization in Ad2 infected HeLa
cells. The three-dimensional
organization of VA RNAI is
visualized as small, round bodies in
the nucleoplasm. The cytoplasmic
portion of VA RNAI is diffusely
distributed.
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ingly, fibrillarin is present in the nucleolar U3 snRNP
(Lischwe et al., 1985; Ochs et al., 1985a; Reimer et al.,
1987; Reddy and Busch, 1988). U3 snRNA has been impli-
cated in the first steps of pre-rRNA processing (Kass et al.,
1990; Tollervey et al., 1991). Therefore, the localization of
DAI with fibrillarin may be of functional significance. More-
over, by immunoelectron microscopy, we found DAI to be
present in the dense fibrillar component of the nucleolus,
although a small amount of label was also found in the fib-
rillar centers and in the granular component of the nucleo-
lus. A possible role of DAI in the first steps of ribosome
biogenesis, indicated by its presence in the dense fib ri l l a r
component of the nucleolus, remains to be demonstrated.
The presence of VA RNAI in the cytoplasm of Ad2-
infected HeLa cells was observed after about 10 hpi and
became increasingly evident at later times. Our inability to
detect transcripts before 10 hpi is presumably due to the
low abundance of VA RNAI during the early phase of infec-
tion (Söderlund et al., 1976) and the insensitivity of the in
situ hybridization technique used. Unlike DAI, the obser-
vation of this RNA in the nucleus was not unexpected since
adenovirus transcripts are produced in the nucleus of the
host cell during the lytic cycle (Akusjärvi et al., 1986). Sur-
prisingly, highly organized structures containing VA RNAI
appear by 10-14 hpi as spherical bodies in the nucleoplasm,
becoming larger and more numerous as the infectious cycle
progresses. These bodies represent a subset of the total ade-
novirus RNA (Jiménez-García and Spector, 1993) and
suggest a mechanism of accumulation and migration for
VA RNAI in the nucleus. Because VA RNAI is transcribed
by RNA polymerase III (Price and Penman, 1972) while
the rest of the viral genome is transcribed by RNA poly-
merase II (see Akusjärvi et al., 1986), the presence of these
bodies containing VA RNAI may be related to a different
site of synthesis and/or transport pathway for transcripts
produced by RNA polymerase III. Supporting this con-
tention is the finding that transfected cells displayed the
same morphological pattern of localization of this RNA as
infected cells, namely the progressive appearance of dots,
suggesting that the transcription and/or transport to the
cytoplasm of RNA polymerase III transcripts may occur via
highly defined nuclear structures. These viral inclusions
containing VA RNAI may represent the viral RNA-rich
compact rings observed by ultrastructural in situ hybridiz-
ation in Ad5-infected cells late in infection (Puvion-
Dutilleul et al., 1992). However, it is unlikely that these
structures are regions of RNA processing since the VA
RNAI is not post-transcriptionally processed.
VA RNAI was expressed in two steps during the late
phase of infection. First, nuclear RNA accumulated as small
round bodies that became numerous. Subsequently, the
RNA accumulated diffusely in the cytoplasm. Indeed, VA
RNAI was visualized in the cytoplasm late in infection, sug-
gesting a final destination corresponding to its function in
the cytoplasm during protein synthesis. These experiments
may suggest a specific signal for VA RNAI to be present
in the cytoplasm. That signal may have something to do
with the molecular structure of the RNA or with the pres-
ence of latent DAI in the cytoplasm. 
DAI (Zilberstein et al., 1976) and VA RNAI (Schneider
et al., 1985) have been found in association with ribosomes.
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Fig. 10. Localization of VA RNAI in transfected HeLa cells. The
morphological pattern of expression for VA RNAI is similar to
that of Ad2 infected HeLa cells. No signal is observed in cells
transfected with plasmid pUC119 (a). By 24 hours (b) after
transfection with pUCVA, VA RNAI appears as fine dots in the
nucleoplasm. At 48 hours (c) the label is more abundant in the
nucleus and some VA RNAI is observed in the cytoplasm. By 60
hours after transfection (d) the nucleus is filled with VA RNAI
excluding the nucleoli. The cytoplasm at this time is heavily
labeled.
21Localization of DAI and VA RNAI
It has been proposed that VA RNAI and Ad2 mRNAs are
associated in infected cells in a manner that results in a
functional compartmentalization (O’Malley et al., 1989).
The presence of the VA RNAI protects the translation of
Ad2 mRNAs from DAI activation by virally generated
dsRNA, while cellular mRNAs, which do not bind VA
RNAI are not protected and therefore not translated. The
colocalization of DAI with VA RNAI in the cytoplasm may
represent such a compartmentalization. Furthermore, the
presence of both DAI and VA RNAI in the nucleus, though
predominantly not colocalized, suggests the possibility that
the association between Ad2 mRNAs, VA RNAI and DAI
may originate in the nucleus prior to export into the cyto-
plasm. Future experiments will examine the organization of
other translational elements in the cytoplasm of Ad2-
infected cells.
In summary, we have shown that DAI is present in the
cytoplasm, in the nucleoplasm, and in the nucleolus of unin-
fected and Ad2-infected HeLa cells. In the nucleolus, DAI
was found predominantly, although not exclusively, in the
dense fibrillar component. On the other hand, VA RNAI
was also present in the cytoplasm and in the nucleus of
Ad2-infected HeLa cells. In the nucleus, VA RNAI was
observed to be present in abundant, highly organized, small,
round structures distributed in the nucleoplasm, but was
excluded from the nucleolus. Both DAI and VA RNAI were
diffusely localized in the cytoplasm.
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